Search

Your search keyword '"Oka, Shinichi"' showing total 1,997 results

Search Constraints

Start Over You searched for: Author "Oka, Shinichi" Remove constraint Author: "Oka, Shinichi"
1,997 results on '"Oka, Shinichi"'

Search Results

1. Clustering of Polymorphic Membrane Protein E Clade in Chlamydia trachomatis Lineages from Men Who Have Sex with Men

4. Prevalence of Asymptomatic Mpox among Men Who Have Sex with Men, Japan, January-March 2023

6. Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial

7. Intravenous infusion of auto-serum-expanded autologous mesenchymal stem cells into chronic severe brain injury patients

17. Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial

23. CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

31. Intravenous Infusion of Autologous Mesenchymal Stem Cells Expanded in Auto Serum for Chronic Spinal Cord Injury Patients: A Case Series.

32. Identification of New Circulating Recombinant Form of HIV-1 CRF127_07109 in Northern Vietnam.

35. Contribution of proteasome-catalyzed peptide cis -splicing to viral targeting by CD8⁺ T cells in HIV-1 infection

39. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

40. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series

41. Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection

45. CD34-positive monocytes are highly susceptible to HIV-1

47. Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022

48. Asian participants' experience in phase 3/3b studies of long‐acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96

49. Rehabilitation facilitates functional improvement following intravenous infusion of mesenchymal stem cells in the chronic phase of cerebral ischemia in rats

Catalog

Books, media, physical & digital resources